Circumcision surgical procedure
|Circumcision surgical procedure|
Circumcision surgical procedure in males involves either a conventional "cut and stitch" surgical procedure or use of a circumcision instrument or device. In the newborn period (less than 2 months of age), almost all circumcisions are done by generalist physicians using one of three surgical instruments. In the USA, the Gomco clamp is the most utilized instrument, followed by the Mogen clamp and the Plastibell. They are also used worldwide.
Complications may include bleeding, infection, and too little or too much tissue removal. Deaths are rare. After the newborn period, circumcision has a higher risk of complications, especially bleeding and anesthetic complications.
Currently, most circumcisions in boys and men are performed using one of three open surgical methods. The forceps-guided method, the dorsal slit method, and the sleeve resection method are well described by the World Health Organization in their Manual for Male Circumcision under Local Anaesthesia. The Gomco clamp and Mogen clamp are sometimes used after the newborn period, in conjunction with either sutures or cyanoacrylate tissue adhesive to prevent post-operative bleeding.
Circumcision surgical instruments should be distinguished from circumcision devices. Circumcision instruments are used at the time of surgery, and the circumcision is complete at the end of the procedure. The Gomco clamp, the Mogen clamp, and Unicirc are surgical instruments. Circumcision devices remain on the penis for 4 to 7 days and either spontaneously detach or are removed surgically at a subsequent visit. Plastibell, Prepex, Shang Ring and other plastic rings are all circumcision devices, also known as "in situ" devices. Circumcision via instrument results in healing by primary intention and healing via devices is by secondary intention, so healing is delayed. All circumcision procedures should involve adequate injectable or topical anesthesia.
- 1 Circumcision surgical instruments
- 2 Circumcision "in situ" devices
- 3 References
- 4 Further reading
- 5 External links
Circumcision surgical instruments
The Gomco clamp is a surgical instrument used to perform circumcision in all age groups, but is mainly used in newborn circumcision. It is the leading instrument for newborn circumcision in the US. The World Health Organization describes it as having "an impeccable safety record."
After retracting the foreskin, the Gomco bell is placed over the glans at the level of the corona and the foreskin is replaced into the anatomic (natural) position. The yoke is then placed over the bell, trapping the foreskin between the bell and the yoke. The clamp is tightened, crushing the foreskin between the bell and the base plate, and left in place for 5 minutes. The crushed blood vessels provide hemostasis. The flared bottom of the bell fits tightly against the hole of the base plate, so the foreskin may be cut away with a scalpel from above the base plate with no risk of injuring the glans.
Circumcision is rapid and completed in a single session. The total procedure takes less than ten minutes, five minutes of which is spent in waiting for the crushing action to take place. In newborns (<2 months of age), no sutures are needed and bleeding is uncommon. After the newborn period, either sutures or cyanoacrylate tissue adhesive can be used to seal the fused mucosal-skin edge to prevent post-operative bleeding. Because the glans is protected by the bell of the Gomco clamp, injuries to the glans are rare. No parts are left on the penis, so late complications are rare compared to devices like the Plastibell which remain on the penis.
Care must be taken to ensure that the device is properly sterilized between procedures, or transmission of infection may occur.
The American Academy of Pediatrics reviewed one study of 1,000 newborn Gomco circumcisions in a hospital setting in Saudi Arabia and rated it "fair evidence." The study found an overall complication rate of 1.9%. Bleeding occurred in 0.6% of cases, infection in 0.4%, and insufficient foreskin removed in 0.3%.
Because the Gomco clamp is made of three major parts, there is a chance that pieces could be incorrectly assembled from differently-sized units or those produced by different manufacturers. Using mismatched parts results in a device that might not sufficiently crush the foreskin, potentially resulting in bleeding.
The Gomco clamp was invented by Dr. Hiram S. Yellen and Aaron A. Goldstein in 1935. Yellen, an obstetrician-gynecologist in Buffalo, New York sought an improved method of newborn circumcision. Goldstein was a prolific local inventor and manufacturer. Gomco stands for the GOldstein Medical COmpany, the original manufacturer of the instrument. The patent was in the name of Aaron Goldstein (U.S. Patent 119180, issued February 27, 1940). The instrument was a rapid success and was widely marketed and sold in the US and Canada. It is currently manufactured and marketed worldwide.
Multiple surveys in the USA estimate that the rate of male circumcision ranges from 42% to 80% among various populations. The Gomco clamp is the leading instrument used to perform non-ritual male circumcision in the United States. There is little information concerning prevalence of Gomco use outside of the USA.
A 1998 survey found that the Gomco clamp was the preferred technique by 67% of American physicians, whereas Plastibell was used by 19% and the Mogen clamp by 10%.
The Mogen clamp is a surgical instrument which permits rapid circumcision. It is most often used in the newborn period, particularly for Jewish ceremonial circumcision (Bris), but is also used in older boys. The newborn version has two flat blades that open 2.5 mm. The Mogen clamp is widely used around the world.
The foreskin is first extended using several straight hemostats. The Mogen clamp is then slid over the foreskin. After confirming that the tip of the glans is free of the blades, the clamp is locked, and a scalpel is used to cut the skin from the flat (upper) side of the clamp. In newborns, no sutures are required. Outside of the newborn period, cyanoacrylate tissue adhesive can be used instead of sutures.
The Mogen clamp has no parts to assemble, is easy to use, and results in a bloodless circumcision with minimal scarring. A single size can be used for infants, obviating any sizing errors. It is rapid, but requires five minutes of clamping to prevent post-operative bleeding. Any complications are immediate, because the instrument is not left on the penis, so they can be dealt with on site. The clamp can be safely used by non-physician healthcare workers in resource-limited settings
Care must be taken to ensure that the device is properly sterilized between procedures, or transmission of infection may occur. The instrument does not directly protect the glans during the procedure, so there is a risk that the glans can be pulled into the slit and crushed or partially severed.
In July 2010, one company manufacturing Mogen clamps (Mogen Circumcision Instruments of New York) went out of business following a lawsuit in which the doctor entirely removed the head of the penis from the child. The court awarded the plaintiff $10 million in damages. This came following similar lawsuits in 2007 and 2009, which awarded $7.5 million and $2.3 million, respectively. According to the American Academy of Pediatrics, there are no good studies of complications of the Mogen clamp because complications are rare; thus, one can only rely on available case reports of glans injuries.
The word mogen is derived from the Hebrew word for “shield.” The Mogen clamp was introduced by Dr Harry Bronstein in 1955. Long before the advent of the Mogen clamp, providers used a simple shield with a narrow gap that protected the glans while the foreskin was pulled through and excised. Providers modified this simple shield and began using instruments that produced a crushing action. Still used in many parts of the world, bone cutters are used to shield the glans, crush the foreskin tissue and guide the scalpel for a clean incision. The Mogen clamp is a refinement of these ancient techniques.
Unicirc is a single-use-only, disposable surgical instrument, which permits rapid minimally-invasive circumcision of males from infancy to adulthood.
After the foreskin is retracted, Unicirc's transparent bell is placed over the glans at the level of the corona and the foreskin is then replaced into the anatomic (natural) position. The yoke is placed over the bell and the screws are tightened, compressing the foreskin for 5 minutes, which fuses the mucosal and skin surfaces. This allows for bloodless excision of the foreskin. Other than a scalpel, no surgical instruments are needed. The fused skin edges are sealed with cyanoacrylate tissue adhesive. The procedure is completed in 9 minutes with no subsequent visits needed.
Unicirc is a single-use-only instrument with a locking device that prevents reuse, eliminating the possibility of transmission of infection from one person to another. It has a transparent polycarbonate bell, so the glans is protected and can be visualized at all times. Topical anesthetic cream is used instead of injectable anesthetic and the use of cyanoacrylate tissue adhesive obviates the need for sutures. It is quick to perform and is completed in a single visit, healing by primary intention is rapid, and cosmetic results are excellent.
Unicirc can also be used in males when the foreskin is tight or adherent to the glans (phimosis), after a dorsal slit (similar to that performed in newborns). Frenulectomies can be performed under topical anesthetic immediately prior to Unicirc circumcision.
An international group of researchers estimated that compressive instruments (like Unicirc and Gomco) could displace up to 85% of surgical circumcisions. A meta-analysis of randomized controlled trials suggested that compressive instruments were associated with less blood loss, more rapid healing, and less pain compared to other techniques.
The risk of tetanus following surgical circumcision is low, and the risk with Uncirc is likely even lower, as there is never an open wound, no necrotic material, and the fused line of excision is sealed with cyanoacrylate, which has antibacterial properties.
As a result of intraoperative and postoperative bleeding episodes using Unicirc version 1, the developers made changes to the tightening mechanism. The current version 2 has the same bleeding risk as surgical circumcision. A small proportion of patients experience partial wound separation in the following week, which does not require treatment.
Accucirc is an instrument designed for newborns which crushes and cuts off the foreskin in a single actuation. The Winkelmann clamp is a sterilizable Gomco-like instrument which consists of a single unit, so mismatching of parts cannot occur.
Circumcision "in situ" devices
All "in situ" devices are based upon steel circumcision rings originally patented by Cecil Ross in 1939. Plastibell is the direct progenitor. All consist of a plastic ring which is inserted beneath the foreskin at the level of the corona and have a ligature (or ligature device) which acts as a tourniquet. This necroses the remaining part of the foreskin and the device either detaches spontaneously after 4 to 7 days, or is removed surgically at one week.
Initial implementation of "in situ" devices for HIV prevention has failed to demonstrate potential advantages with regard to efficiency or cost, compared to conventional surgical circumcision.
Plastibell' is a single-use disposable plastic device mainly used to circumcise infants, but it can be used for boys up to 12 years of age.
The Plastibell plastic ring is placed under the foreskin and secured with a circumferential ligature, which prevents bleeding when the distal foreskin is excised. The entire procedure takes five to ten minutes. The ring falls off after 4 to 7 days, leaving a circumferential wound that heals by secondary intention in one to two weeks.
Plastibell is a single-use-only disposable device, which prevents reuse and potential transmission of infection. The glans is protected during the procedure by the ring, so there is a reduced risk of injury to the glans, compared to the Mogen clamp. It is a rapid procedure which can be done under clean (rather than sterile) conditions. No bandage is required, allowing for easy monitoring for bleeding or infection.
The American Academy of Pediatrics estimates that overall complications occur in from 2.4% to 5% of Plastibell procedures. The risk of bleeding is 1%, similar to the risk with the Gomco clamp and Mogen clamp. A significant complication can occur if the glans swells and herniates (protrudes) through the ring. This worsens the swelling and can reduce blood and urine flow, resulting in serious long-term sequelae. Unlike complications occurring with surgical instruments that are dealt with immediately, this complication occurs hours to days after the patient leaves the clinic and must be dealt with promptly to prevent serious complications. Therefore, Plastibell should only be used when follow-up is rapidly available.
The idea of using a tourniquet approach to infant circumcision is attributed to Dr Cecil J. Ross who patented steel circumcision rings in 1939. Subsequently, Dr Kariher patented a plastic ring with a removable handle in 1955. Plastibell comes in a sterile package with a single ligature and is distributed by the Hollister Company (Libertyville, IL).
PrePex is a medical circumcision device developed as part of a comprehensive HIV prevention strategy in Sub-Saharan Africa. The device is not for self-use, and is only intended for males aged 13 years or older.
The disposable plastic device comprises four elements: a placement ring, an inner ring, an elastic band and a verification thread. The elastic band traps the foreskin against the plastic ring, stopping the flow of blood and oxygen to the foreskin tissue, initiating ischemic necrosis. Prepex requires a separate visit for device removal at one week, when the dead tissue is excised with scissors and the ring is removed.
Prepex is a single-use-only disposable device, which prevents disease transmission from reuse. It requires neither injectable anesthetic nor sutures. Prepex is simple and rapid to apply in a non-sterile environment by doctors, nurses, and clinical officers. Application causes minimal pain.
Like other "in situ" devices, complications can occur up to several days following the placement procedure and must be dealt with promptly to prevent serious complications. Prepex should only be used when surgical care is rapidly available.
Following six cases of tetanus that occurred after Prepex circumcision, WHO recommends a course of tetanus immunizations with the final dose > 2 weeks before Prepex placement.
Men complain of odor from the necrotic foreskin and device removal after one week is painful. Healing is by secondary intention and is therefore delayed compared to techniques which allow for healing by primary intention. There is a risk of HIV transmission if men engage in unprotected sex before the wound is healed. Thus, Prepex circumcision requires a longer period of post-circumcision sexual abstinence than surgical or instrumental methods.
PrePex was developed in 2009 in Israel and is marketed by Circ Med Tech, Ltd. It is WHO-approved for boys > 13 years of age. PrePex is cleared by the U.S. Food and Drug Administration (FDA), under the 510(k) mechanism with SmartKlamp as the predicate device. It is a Mark Class IIa device approved for adult men. In April 2012, PrePex won the Best Technology for Health Award.
PrePex is being used for adult male circumcision for HIV prevention in 14 priority countries in Sub-Saharan Africa with high HIV prevalence, and the device is not yet available elsewhere. Multiple countries are currently scaling-up Prepex use.
The Shang Ring is a disposable plastic "in situ" device for male circumcision. It has been studied in China and Africa, and has been approved by WHO for circumcision in males > 13 years of age to prevent HIV.
The Shang Ring consists of two concentric medical grade plastic rings: an inner ring with a silicone band and an outer, hinged ring that acts as a ligature. The appropriate size is determined through use of a measuring strip. The inner ring is placed underneath the foreskin. The outer (hinged) ring is placed on the outside of the foreskin and locks against the inner ring when snapped together. The distal foreskin is then excised. The Shang Ring is removed after one week when the outer ring locking mechanism is opened using a special tool. A pair of scissors, specifically designed for this purpose, is then used to remove the inner ring.
Shang Ring is simple, disposable, easy to use, and has good cosmetic results, providing sutureless circumcision that may be an acceptable alternative to current surgical techniques.
Like other "in situ" devices, complications may occur up to several days following the placement procedure and must be dealt with promptly to prevent serious sequelae. Shang Ring should only be used when surgical care is rapidly available.
In a review by WHO personnel, 0.4% men required rapid intervention with surgical circumcision as the excision had occurred but the foreskin slipped from the device and required suturing. No serious adverse events occurred; 1% experienced moderate adverse events from a total of 1983 successful device placements. All adverse events were managed with minor interventions and resolved without long-term sequelae. Rates were similar to those observed with conventional surgical circumcision. In settings where skilled surgeons are mostly located in urban centers, referral of clients who require surgical management of device-related complications within the recommended time frame of 6–12 hours may not be possible.
Healing is by secondary intention and is therefore delayed compared to techniques which allow for healing by primary intention. There is a risk of HIV transmission if men engage in unprotected sex before the wound is healed. Thus, Shang Ring circumcision requires a longer period of post-circumcision sexual abstinence than surgical or instrumental methods.
The Shang Ring was developed by Jianzhong Shang in 2003 and is manufactured by Wuhu SNNDA Medical Treatment Appliance Technology Co., Ltd, Wuhu, Anhui Province, China. The Shang Ring has been approved by WHO, and is cleared by the U.S. FDA under the 510(k) mechanism with Plastibell as the predicate device.
Shang ring is being used in HIV prevention programs in the 14 countries in sub-Saharan Africa where HIV is most common.
Other plastic ring devices
Many other plastic ring devices exist, none of which has thus far gained significant market share. Circumplast is a Plastibell-like device which uses a cylinder instead of a ring, which aids in more easily placing the ligature and prevents damage to the glans. Tara Klamp, SmartKlamp, and Ali's Klamp are all "in situ" ring devices for boys and men.
- Stang, HJ; Snellman, LW (1998). "Circumcision practice patterns in the United States". Pediatrics. 101 (6): –5. doi:10.1542/peds.101.6.e5. PMID 9606247.
- Manual for early infant male circumcision under local anaesthesia. Geneva: World Health Organization. 2010.
- Krill AJ, Palmer LS, Palmer, JS. Complications of circumcision. The Scientific World Journal. 2011;11:2458–2468. doi:10.1100/2011/373829. PMID 22235177.
- Williams N, Kapila L. Complications of circumcision. Br J Surg. 1993;80(10):1231–36. doi:10.1002/bjs.1800801005. PMID 8242285.
- American Academy of Pediatrics Task Force on Circumcision (2012). "Technical Report". Pediatrics. 130 (3): e756–e785. doi:10.1542/peds.2012-1990. ISSN 0031-4005. PMID 22926175.
- "Manual for male circumcision under local anaesthesia". Geneva: World Health Organization. December 2009.
- Lane, V; Vajda, P; Subramaniam, R (2010). "Paediatric sutureless circumcision: a systematic literature review". Pediatr Surg Int. 26 (2): 141–4. doi:10.1007/s00383-009-2475-y. PMID 19707772.
- Framework for Clinical Evaluation of Devices for Adult Male Circumcision (PDF) (Report). WHO. 2007. Archived from the original (PDF) on 2011-11-14. Retrieved 2017-04-18.
- Ridzon, R; Reed, JB; Sgaier, SK; Hankins, C (2016). "VMMC Devices-Introducing a New Innovation to a Public Health Intervention". Journal of Acquired Immune Deficiency Syndromes. 72 Suppl 1: –1–4. doi:10.1097/QAI.0000000000000967. PMC 4936419. PMID 27331583.
- Wan, J (2002). "Gomco circumcision clamp; an enduring and unexpected success". Urology. 59 (5): 790–794. doi:10.1016/s0090-4295(01)01320-6. PMID 11992930.
- Kankaka EN, Murungi T, Kigozi G, et al. Randomised trial of early infant circumcision performed by clinical officers and registered nurse midwives using the Mogen clamp in Rakai, Uganda. BJU Int. September 2016. doi:10.1111/bju.13589.
- Fowler, Grant C.; Pfenninger, John L. (2003). Pfenninger and Fowler's procedures for primary care. St. Louis: Mosby. ISBN 978-0-323-00506-7.[page needed]
- Reynolds RD (July 1996). "Use of the Mogen clamp for neonatal circumcision". American Family Physician. 54 (1): 177–82. PMID 8677833.
- Tagami, Ty. "Atlanta lawyer wins $11 million lawsuit for family in botched circumcision". ajc. Retrieved 2017-05-24.
- "5 studies found for Unicirc". ClinicalTrials.gov. Retrieved 1 Feb 2017.
- Fram F, Church F, Sundaram M, et al. (2016). "Employing Demand-Based Volumetric Forecasting to Identify Potential for and Roles of Devices in Scale-Up of Medical Male Circumcision in Zambia and Zimbabwe". Journal of Acquired Immune Deficiency Syndromes. 72 Suppl 1:S83-9: S83–9. doi:10.1097/QAI.0000000000000991. PMC 4936429. PMID 27331597.
- Fan Y, Cao D, Wei Q, et al. (2016). "The characteristics of circular disposable devices and in situ devices for optimizing male circumcision: a network meta-analysis". Scientific Reports. 6: 25514. doi:10.1038/srep25514. PMC 4860598. PMID 27156368.
- Barrie, H.; Huntingford, P. J.; Gough, M. H. (1965). "The Plastibell Technique for Circumcison". BMJ. 2 (5456): 273–5. doi:10.1136/bmj.2.5456.273. PMC 1845746. PMID 14310205.
- "9 studies found for PrePex". ClinicalTrials.gov. Retrieved 20 April 2014.
- Farley, Tim. "Adult Male Circumcision Devices". PowerPoint Presentation. World Health Organization. Archived from the original on 2014-06-06. Retrieved 30 May 2014.
- "Clinical Procedure". Prepex. Archived from the original on 2014-04-27. Retrieved 20 April 2014.
- "Non-surgical male circumcision device" (PDF). WHO Medical Devices. WHO. Retrieved 20 April 2014.
- Odoyo-June, E.; Feldblum, P.J.; Fischer, S.; et al. (2016). "Unexpected Complications Following Adult Medical Male Circumcision Using the PrePex Device". Urologia Internationalis. 96 (2): 188–193. doi:10.1159/000442753. ISSN 0042-1138. PMID 26684654.
- "Tetanus and voluntary medical male circumcision: risk according to circumcision method and risk mitigation". WHO. 2016.
- Feldblum, PJ; Odoyo-June, E; Bailey, RC; et al. (2016-06-01). "Factors Associated With Delayed Healing in a Study of the PrePex Device for Adult Male Circumcision in Kenya". Journal of Acquired Immune Deficiency Syndromes. 72 Suppl 1: –24–29. doi:10.1097/QAI.0000000000000736. PMC 4936424. PMID 27331586.
- WHO Technical Advisory Group on Innovations in Male Circumcision: Evaluation of Two Adult Devices (PDF) (Report). Geneva. 2013.
- "WHO Technical Advisory Group on Innovations in Male Circumcision: Evaluation of Two Adult Devices" (PDF). WHO. Retrieved 20 April 2014.
- "501(K) Summary for PrePex" (PDF). FDA. Retrieved 30 May 2014.
- "Technology for Health 2012 Winner: PrePex by Circ MedTech" (PDF). GBC Health. Retrieved 20 April 2014.
- McNeil, Donald G., Jr. (Aug 13, 2012). "Africa: Nonsurgical Circumcision Device Will Be Tested to Help Curb AIDS". The New York Times. Retrieved 30 May 2014.
- Cao, D; L, L; Hu, Y; et al. (2015). "A systematic review and meta-analysis of circumcision with Shang Ring vs conventional circumcision". Urology. 85 (4): 799–804. doi:10.1016/j.urology.2014.12.007. ISSN 1527-9995. PMID 25711156.
- Samuelson J, Baggaley R, Hirnschall G (2013). "Innovative Device Methods for Adult Medical Male Circumcision for HIV Prevention: Lessons From Research". Journal of Acquired Immune Deficiency Syndromes. 64 (2). ISSN 1525-4135.
- 510(k) -Summary for the Wuhu Snnda Medical Treatment Appliance Technology Co., Ltd. ShangRing (PDF) (Report). 2012.
- Siegfried N, Muller M, Deeks JJ, Volmink J. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2009;(2):CD003362. Epub 2009/04/17. doi:10.1002/14651858.CD003362.pub2 PubMed PMID 19370585.
- Update: Voluntary Medical Male Circumcision. UNAIDS. 2016.